Matches in Nanopublications for { ?s ?p "DDI between Tretinoin and Lapatinib - The moderate CYP2C8 inhibitor, Lapatinib, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Lapatinib is initiated, discontinued to dose changed. [drugbank_resource:DB00755_DB01259]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00755_DB01259 label "DDI between Tretinoin and Lapatinib - The moderate CYP2C8 inhibitor, Lapatinib, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Lapatinib is initiated, discontinued to dose changed. [drugbank_resource:DB00755_DB01259]" assertion.